Table 3.
Formulation/Route of Administration | Time to Peak1—Assess for Efficacy and Adverse Effects | Additional Considerations |
---|---|---|
Intravenous | 10–15 min | |
Subcutaneous | 30 min | |
Immediate release oral | 60 min | |
Immediate release sublingual | 15–30 min | Assess patient ability to hold medication under the tongue |
Expected time to peak based on route of administration in otherwise healthy patients without organ dysfunction. Reference: [11].